🟢 Heron Therapeutics is trading 6% up in after-hours trading with no confirmed company-specific catalyst

Heron Therapeutics is trading 6.14% higher at $0.32, compared with its October 27 regular-session close of $0.30; no confirmed company-specific news explains the after-hours rise.

• The stock had been near $0.30 for several sessions.
• The company announced a November 9 call to report third-quarter results, but the scheduled event does not establish a cause for the move.
• Broader market sentiment was positive, though available evidence does not show it directly drove the after-hours change.